117 related articles for article (PubMed ID: 38522310)
1. Encapsulation of the growth factor neurotrophin-3 in heparinised poloxamer hydrogel stabilises bioactivity and provides sustained release.
Meissner S; Rees S; Nguyen L; Connor B; Barker D; Harland B; Raos B; Svirskis D
Biomater Adv; 2024 May; 159():213837. PubMed ID: 38522310
[TBL] [Abstract][Full Text] [Related]
2. Using NGF heparin-poloxamer thermosensitive hydrogels to enhance the nerve regeneration for spinal cord injury.
Zhao YZ; Jiang X; Xiao J; Lin Q; Yu WZ; Tian FR; Mao KL; Yang W; Wong HL; Lu CT
Acta Biomater; 2016 Jan; 29():71-80. PubMed ID: 26472614
[TBL] [Abstract][Full Text] [Related]
3. Thermosensitive heparin-poloxamer hydrogel encapsulated bFGF and NGF to treat spinal cord injury.
Hu X; Li R; Wu Y; Li Y; Zhong X; Zhang G; Kang Y; Liu S; Xie L; Ye J; Xiao J
J Cell Mol Med; 2020 Jul; 24(14):8166-8178. PubMed ID: 32515141
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release of FGF-2 from a hybrid hydrogel of heparin-poloxamer and decellular matrix promotes the neuroprotective effects of proteins after spinal injury.
Xu HL; Tian FR; Xiao J; Chen PP; Xu J; Fan ZL; Yang JJ; Lu CT; Zhao YZ
Int J Nanomedicine; 2018; 13():681-694. PubMed ID: 29440894
[TBL] [Abstract][Full Text] [Related]
5. An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury.
Liu D; Jiang T; Cai W; Chen J; Zhang H; Hietala S; Santos HA; Yin G; Fan J
Adv Healthc Mater; 2016 Jun; 5(12):1513-21. PubMed ID: 27113454
[TBL] [Abstract][Full Text] [Related]
6. High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide.
Soni G; Yadav KS
Pharm Dev Technol; 2014 Sep; 19(6):651-61. PubMed ID: 23879721
[TBL] [Abstract][Full Text] [Related]
7. Thermosensitive heparin-poloxamer hydrogels enhance the effects of GDNF on neuronal circuit remodeling and neuroprotection after spinal cord injury.
Zhao YZ; Jiang X; Lin Q; Xu HL; Huang YD; Lu CT; Cai J
J Biomed Mater Res A; 2017 Oct; 105(10):2816-2829. PubMed ID: 28593744
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid on the urokinase sustained release with a hydrogel system composed of poloxamer 407: HA/P407 hydrogel system for drug delivery.
Hsieh HY; Lin WY; Lee AL; Li YC; Chen YJ; Chen KC; Young TH
PLoS One; 2020; 15(3):e0227784. PubMed ID: 32160196
[TBL] [Abstract][Full Text] [Related]
9. A cocktail of growth factors released from a heparin hyaluronic-acid hydrogel promotes the myogenic potential of human urine-derived stem cells in vivo.
Liu G; Wu R; Yang B; Shi Y; Deng C; Atala A; Mou S; Criswell T; Zhang Y
Acta Biomater; 2020 Apr; 107():50-64. PubMed ID: 32044457
[TBL] [Abstract][Full Text] [Related]
10. A Thermosensitive Heparin-Poloxamer Hydrogel Bridges aFGF to Treat Spinal Cord Injury.
Wang Q; He Y; Zhao Y; Xie H; Lin Q; He Z; Wang X; Li J; Zhang H; Wang C; Gong F; Li X; Xu H; Ye Q; Xiao J
ACS Appl Mater Interfaces; 2017 Mar; 9(8):6725-6745. PubMed ID: 28181797
[TBL] [Abstract][Full Text] [Related]
11. Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis.
Li Z; Qu T; Ding C; Ma C; Sun H; Li S; Liu X
Acta Biomater; 2015 Feb; 13():88-100. PubMed ID: 25462840
[TBL] [Abstract][Full Text] [Related]
12. Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord.
Elliott Donaghue I; Tator CH; Shoichet MS
Biomater Sci; 2015 Jan; 3(1):65-72. PubMed ID: 26214190
[TBL] [Abstract][Full Text] [Related]
13. Biomineralized biomimetic organic/inorganic hybrid hydrogels based on hyaluronic acid and poloxamer.
Huh HW; Zhao L; Kim SY
Carbohydr Polym; 2015 Aug; 126():130-40. PubMed ID: 25933531
[TBL] [Abstract][Full Text] [Related]
14. An injectable PEG hydrogel controlling neurotrophin-3 release by affinity peptides.
Wang J; Youngblood R; Cassinotti L; Skoumal M; Corfas G; Shea L
J Control Release; 2021 Feb; 330():575-586. PubMed ID: 33378693
[TBL] [Abstract][Full Text] [Related]
15. Heparin-poloxamer hydrogel-encapsulated rhFGF21 enhances wound healing in diabetic mice.
Liu H; Zhao Y; Zou Y; Huang W; Zhu L; Liu F; Wang D; Guo K; Hu J; Chen J; Ye L; Li X; Lin L
FASEB J; 2019 Sep; 33(9):9858-9870. PubMed ID: 31166803
[TBL] [Abstract][Full Text] [Related]
16. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro.
Cho KY; Chung TW; Kim BC; Kim MK; Lee JH; Wee WR; Cho CS
Int J Pharm; 2003 Jul; 260(1):83-91. PubMed ID: 12818813
[TBL] [Abstract][Full Text] [Related]
17. Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel.
Stanwick JC; Baumann MD; Shoichet MS
J Control Release; 2012 Jun; 160(3):666-75. PubMed ID: 22510446
[TBL] [Abstract][Full Text] [Related]
18. Thermosensitive Poloxamer 407/Poly(Acrylic Acid) Hydrogels with Potential Application as Injectable Drug Delivery System.
Boonlai W; Tantishaiyakul V; Hirun N; Sangfai T; Suknuntha K
AAPS PharmSciTech; 2018 Jul; 19(5):2103-2117. PubMed ID: 29696613
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
Taylor SJ; McDonald JW; Sakiyama-Elbert SE
J Control Release; 2004 Aug; 98(2):281-94. PubMed ID: 15262419
[TBL] [Abstract][Full Text] [Related]
20. Sustained neurotrophin-3 delivery from hyaluronic acid hydrogels for neural tissue regeneration.
Ramos Ferrer P; Vardhan S; Sakiyama-Elbert S
J Biomed Mater Res A; 2024 Aug; 112(8):1188-1199. PubMed ID: 37675824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
